Skip to main content

Table 1 Descriptive statistics of baseline outcomes

From: Dynamics of retinal changes in early-stage Parkinson’s disease

 

Control

PD

p

n

Mean (SD)

n

Mean (SD)

Demographics

     

Age (years old)

52

64.1 (7.8)

53

64.3 (7.6)

0.889

Sex, n (% females)

52

33 (64.7)

53

18 (35.3)

0.005 **

Education years

52

11.6 (3.0)

53

11.1 (3.5)

0.900

Hypertension (n, %)

52

24 (26.3%)

53

27 (30%)

0.706

Disease-related variables

     

Disease duration (years)

 

NA

53

2.5 (1.4)

NA

UPDRS I

 

NA

49

1.8 (1.6)

NA

UPDRS II

 

NA

49

7.5 (1.6)

NA

UPDRS III

 

NA

51

21.5 (11.3)

NA

UPDRS IV

 

NA

50

2.3 (2.8)

NA

LEDD (mg)

 

NA

53

395.3 (260.2)

NA

H&Y stage (n, %)

1

   

16 (30.2%)

 

1.5

   

2 (3.8%)

 

2

   

25 (47.2%)

 

2.5

   

2 (3.8%)

 

3

   

4 (7.5%)

 

Primary visual outcomes

     

High Contrast VA (no. of letters)

50

44.6 (3.6)

52

43.4 (4.8)

0.136

Low Contrast VA (no. of letters)

50

29.8 (6.0)

52

25.0 (9.6)

0.003 **

CS (no. of letters)

50

72.5 (10.6)

52

66.9 (17.7)

0.008 **

CS, contrast % §

50

1.04 (0.28)

52

1.56 (1.18)

0.006 **

Farnsworth D-15 §

48

127.0 (17.6)

50

142.9 (35.7)

0.008 *

Cognitive outcomes

     

MoCA

49

24.4 (3.0)

51

23.2 (3.7)

0.088

Visual Attention ǂ

45

0.16 (0.81)

38

-0.19 (0.89)

0.041*

Visual Perception ǂ

45

0.08 (0.81)

37

-0.07 (0.70)

0.077

Visual Executive functions ǂ

45

0.18 (0.69)

38

-0.18 (0.84)

0.010 *

  1. Data are represented as mean (SD) unless otherwise specified. The number of correctly identified letters was recorded for visual acuity and contrast sensitivity testing. p-values for primary visual and cognitive outcomes were extracted from group effects in LMMs. These models were adjusted for age at baseline, sex and the hypertension status for primary visual outcomes, and for age at baseline, sex, hypertension status, and years of education for cognitive scores. § Higher values indicate worse outcome. ǂ Composite scores of visual cognitive functions in z-score
  2. Statistical significance: *p < 0.05, ** p < 0.01, *** p < 0.001. Abbreviations: CS, contrast sensitivity; LEDD, levodopa-equivalent daily dose; H&Y, Hoenh&Yahr scale; MoCA, Montreal Cognitive Assessment; NA, not applicable; VA, visual acuity